Option Care Health, Inc. (NASDAQ:OPCH) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of Option Care Health, Inc. (NASDAQ:OPCH) have received an average rating of “Moderate Buy” from the thirteen ratings firms that are currently covering the company, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $35.10.

A number of research firms recently weighed in on OPCH. Weiss Ratings reiterated a “hold (c)” rating on shares of Option Care Health in a research note on Saturday. TD Cowen started coverage on Option Care Health in a research report on Thursday, October 2nd. They issued a “hold” rating and a $30.00 price target for the company. Barrington Research reiterated an “outperform” rating and issued a $38.00 price target on shares of Option Care Health in a research report on Tuesday, September 23rd. Cowen began coverage on Option Care Health in a research report on Thursday, October 2nd. They issued a “hold” rating for the company. Finally, Citigroup reaffirmed an “outperform” rating on shares of Option Care Health in a report on Thursday, July 31st.

Insider Activity at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 36,000 shares of Option Care Health stock in a transaction dated Wednesday, August 20th. The stock was purchased at an average cost of $27.15 per share, for a total transaction of $977,400.00. Following the transaction, the director directly owned 375,390 shares of the company’s stock, valued at approximately $10,191,838.50. This trade represents a 10.61% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Norman L. Wright purchased 3,411 shares of Option Care Health stock in a transaction dated Tuesday, September 9th. The shares were purchased at an average price of $29.31 per share, with a total value of $99,976.41. Following the completion of the transaction, the director directly owned 15,501 shares in the company, valued at approximately $454,334.31. This represents a 28.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders bought 59,411 shares of company stock valued at $1,627,576. Corporate insiders own 0.64% of the company’s stock.

Hedge Funds Weigh In On Option Care Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. USA Financial Formulas purchased a new position in shares of Option Care Health during the second quarter worth about $26,000. Northwestern Mutual Wealth Management Co. grew its holdings in shares of Option Care Health by 1,492.9% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company’s stock worth $31,000 after purchasing an additional 836 shares in the last quarter. McIlrath & Eck LLC purchased a new position in Option Care Health in the 2nd quarter worth approximately $37,000. Elevation Point Wealth Partners LLC purchased a new position in Option Care Health in the 2nd quarter worth approximately $40,000. Finally, Brooklyn Investment Group grew its stake in Option Care Health by 186.6% in the 1st quarter. Brooklyn Investment Group now owns 1,198 shares of the company’s stock worth $42,000 after buying an additional 780 shares in the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Trading Down 0.5%

Shares of OPCH opened at $27.91 on Monday. The business has a 50-day moving average of $27.99 and a 200 day moving average of $30.07. Option Care Health has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The firm has a market cap of $4.53 billion, a P/E ratio of 22.33, a price-to-earnings-growth ratio of 1.69 and a beta of 0.88. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52.

Option Care Health (NASDAQ:OPCH) last posted its earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.01. The firm had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.35 billion. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The company’s revenue was up 15.4% on a year-over-year basis. During the same quarter last year, the company earned $0.30 earnings per share. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, research analysts forecast that Option Care Health will post 1.22 EPS for the current year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.